Regeneron pharmaceuticals, inc. sued for securities law violations - investors should contact levi & korsinsky for more information - regn

New york, ny / access newswire / february 3, 2025 / if you suffered a loss on your regeneron pharmaceuticals, inc. (nasdaq:regn) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=126696&wire=1 or contact joseph e. levi, esq.
REGN Ratings Summary
REGN Quant Ranking